Newark, New Castle, USA, March 31, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Growth Plus Reports, the global female pelvic implants market was valued at US$ 232.50 billion in 2022 and is expected to surpass US$ 318.58 billion by 2031, at a revenue CAGR of 3.20%. The report analyzes top winning strategies, drivers & opportunities, competitive scenarios, wavering market trends, market size, statistics & estimations, and major investment pockets.
Key Takeaways:
- The rising prevalence of female pelvic organ prolapse (POP) and stress urinary incontinence will provide plenty of growth opportunities for the female pelvic implant market.
- North America will dominate the global female pelvic implant market.
- Increasing public awareness will fuel the growth of the female pelvic implant market.
Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/female-pelvic-implants-market/8468
Female Pelvic Implants Market Scope
| Report Attribute | Details |
| Market size value in 2022 | US$ 232.5 million |
| Revenue forecast in 2031 | US$ 318.58 billion |
| Growth Rate | CAGR of 3.2% from 2023 to 2031 |
| Base year for estimation | 2022 |
| Forecast Period | 2023-2031 |
| Historical Year | 2021 |
| Segments covered | Product Type, Indication, End-user, and Region. |
| Regional scope | North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
Market Drivers
The rising prevalence of female pelvic organ prolapse (POP) and stress urinary incontinence (SUI) is driving the revenue growth of the global market. Furthermore, increased awareness of pelvic floor disorders and treatment alternatives, a rise in the number of pelvic implant surgeries performed, and the availability of non-surgical treatments for pelvic organ prolapses and stress urinary incontinence will support market revenue growth.
Market Segmentation
Growth Plus Reports has analyzed the global female pelvic implants market from three perspectives: Product Type, Indication, End-user, and Region.
Product Type Segmentation: Based on the product type, the global female pelvic implants market is segmented into vaginal mesh and vaginal sling/tape. The vaginal mesh segment dominates the market with the largest revenue share because it is widely used to treat pelvic organ prolapse and stress urinary incontinence.
Indication Segmentation: Based on the indication, the global female pelvic implant market is segmented into pelvic organ prolapse and stress urinary incontinence. The stress urinary incontinence segment dominates the market with the largest revenue share because of its rising prevalence among females.
End-User Segmentation: Based on the end-user, the female pelvic implants market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospital segment dominates the market with the largest revenue share because hospitals have specific women's health departments, including pelvic floor disorder clinics, and hospitals play a role in developing and testing novel implant devices.
Regional Growth Dynamics
Based on the region, the global female pelvic implants market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the global female pelvic implants market due to prominent market players, the growing prevalence of pelvic organ prolapse and stress urinary incontinence, significant healthcare spending, and the introduction of new and innovative products in this region.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/female-pelvic-implants-market/8468
Competitive Landscape
The major players operating in the global female pelvic implants market are:
- Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.)
- Boston Scientific Corporation
- Promedon GmbH
- Becton, Dickinson, and Company
- Cook Medical
- Dipromed Srl
- Caldera Medical
- Betatech Medical
- CurvaFix Inc.
- C.R. Bard, Inc.
The female pelvic implant market is moderately competitive, with few key players. Key players operating in the market are implementing competitive tactics such as product development and regional presence growth. Major companies are aggressively acquiring other companies to strengthen their global market positions.
Recent developments:
- Neuspera Medical announced in October 2022 that the first patient in their clinical study had been successfully implanted with the Nuvella system (SANS-UUI). The Nuvella device, designed to treat overactive bladder (OAB) symptoms with sacral neuromodulation (SNM), will be tested for safety and efficacy in the trial.
- Coloplast acquired Nine Continents Medical, Inc. to expand its medical device product range in November 2020
- InterStim announced in August 2020 that their Micro neurostimulator and SureScan MRI had received FDA approval for non-obstructive urinary retention, overactive bladder, and fecal incontinence.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- Reimbursements
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL FEMALE PELVIC IMPLANTS MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
- Vaginal Mesh
- Vaginal Sling/Tape
- GLOBAL FEMALE PELVIC IMPLANTS MARKET - ANALYSIS & FORECAST, BY INDICATION
- Pelvic Organ Prolapse
- Stress Urinary Incontinence
- GLOBAL FEMALE PELVIC IMPLANTS MARKET - ANALYSIS & FORECAST, BY END-USER
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
FEMALE PELVIC IMPLANTS MARKET TOC
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8468
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Browse related reports:
Hereditary Spastic Paraplegia Market by Drug Class (Skeletal Muscle Relaxants, Anxiolytics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook and Forecast 2023-2031
Femoral Nail System Market by Patient Type (Pediatric, Adults), Indications (Spiral or Transverse, Comminuted, and Open) - Global Outlook and Forecast 2023-2031
External Fixation System Market by Product (Manual Fixator, Computer-aided Fixators), Type (Unilateral, Bilateral), Application (Orthopedic Deformities, Fracture Fixation), End User (Hospitals, Ambulatory Surgical Centers) - Global Outlook and Forecast 2023-2031
Disposable PPE Market by Product Type (Protective Clothing, Respiratory Protection), End User (Hospitals, Home Healthcare) – Global Outlook & Forecast 2023-2031
Automated Immunoassay Analyzers Market by Product (Immunofluorescence, Chemiluminescence) Application (Infectious Diseases, Endocrinology,) End User (Academic Research Institutes, Biotech and Pharma Companies) – Global Outlook & Forecast 2023-2031
Artificial Cartilage Implants Market by Anatomy of Joints (Upper Extremity Joints, Lower Extremity Joints), End User (Hospitals, Ambulatory Surgical Centers) – Global Outlook & Forecast 2023-2031
Veterinary Imaging Market by Product (X-ray, Ultrasound, MRI), Application (Cardiology, Neurology, Respiratory, Orthopedics, and Traumatology), End Use (Veterinary Hospitals & Clinics, Other End-use)- Global Outlook and Forecast 2023-2031
Rapid Medical Tests Market By Product (Instruments, Consumables), Technology (Immunoassay, Molecular diagnostics), Application (Upper Respiratory Tract Infections), End-user (Hospitals & Clinics) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
